China’s prestigious Healthcare Products Expo (CHEXPO ASEAN) is coming back for its second time in Jakarta from Wednesday to Friday, to promote and enhance cooperation between China and Southeast Asian Countries in the pharmaceutical and medical sectors after succeeding in last year’s exhibition.
Taking place in the Jakarta International Expo in Central Jakarta, this year’s exhibition is featuring an experience zone set up for China and ASEAN countries to exhibit their healthcare products, such as traditional therapies and medicines, food supplements, medical equipment as well as healthcare testing services.
At least 130 Chinese pharmaceutical and medical businesses participated in the event.
Special stalls are also set up for Indonesian companies to feature their local healthcare products, such as bird nest products and “jamu” which is Indonesian traditional herbal drinks that many people in the country still consume in copious quantities, in the hope that they would never have to see doctors.
The products are for Chinese companies to purchase
“China and Indonesia are close neighbours with geographical proximity and cultural affinity. We enjoy a long and deep friendship,” said Zhou Hui, who is the president of the Chamber of Import and Export of Medicines and Health Products.
“Under the leaders from the two countries, the comprehensive strategic cooperative partnership between China and Indonesia has been expanding, and practical cooperation in all fields has been carried out,” he added.
In recent years, China and Indonesia have been promoting the alignment of development strategies of the two countries and made solid progress in practical cooperation.
“We have signed the memorandum of understanding on the Belt & Road Initiative and Global Maritime Axis, and yielded rich fruit in cooperation and exchanges on all fronts. In 2018, our bilateral trade amounted to 77.4 billion U.S. dollars,” said Zhou.
According to Indonesia’s Investment Coordinating Board, the Chinese mainland is Indonesia’s largest trading partner for eight consecutive years. Its direct investment to Indonesia reached 2.4 billion dollars, maintaining the position as Indonesia’s third-largest investor.
“In the first half year of 2019, our direct investment to Indonesia stood at 2.29 billion U.S. dollars, which has already approached last year’s total,” Zhou said.
Separately, Wang Liping, who is the Economic and Commercial Minister Counsellor at the Chinese Embassy in Indonesia, suggested that Indonesian companies use Chinese healthcare products.
“China’s technology in the healthcare sector is already advanced. Companies in China are ready to supply healthcare needs in Indonesia,” Wang said.